Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Therapeutic Advances in Hematology|October 29, 2020
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaPatricia Johansson, Laura Dierichs, Ludger Klein-Hitpass, et al.Cell Chemical Biology|July 16, 2019
Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell GrowthElena S Reckzeh, George Karageorgis, Melanie Schwalfenberg, et al.Science Immunology|August 26, 2018
Gasdermin D plays a vital role in the generation of neutrophil extracellular trapsGabriel Sollberger, Axel Choidas, Garth Lawrence Burn, et al.Blood Cancer Journal|January 21, 2018
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaPatricia Johansson, Ludger Klein-Hitpass, Axel Choidas, et al.Oncotarget|June 15, 2018
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemiaJoachim R Göthert, Roze Imsak, Michael Möllmann, et al.Journal of the American Chemical Society|April 7, 2012
Psoromic acid is a selective and covalent Rab-prenylation inhibitor targeting autoinhibited RabGGTaseCéline Deraeve, Zhong Guo, Robin S Bon, et al.Cell Chemical Biology|May 2, 2023
IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilizationBlaž Andlovic, Geronimo Heilmann, Sabrina Ninck, et al.Nature|December 17, 2020
Small-molecule inhibitors of human mitochondrial DNA transcriptionNina A Bonekamp, Bradley Peter, Hauke S Hillen, et al.Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.Pageof 3